Publications by authors named "Eric Wenzel"

Claim this Profile
A
A prospective cohort analysis from Germany shows transition into adulthood is an underestimated vulnerable period for children with overweight/obesity.
Johannes Riedel, Natascha Genge, Klara Meyer, Eric Wenzel, Elena Sergeyev

Commun Med (Lond)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reference Values for Serum Leptin Levels in Children, Adolescents, and Adults With Normal Weight, Overweight, and Obesity.
Stephanie Brandt-Heunemann, Mandy Vogel, Wieland Kiess, Antje Körner, Matthias Blüher, Eric Wenzel

J Clin Endocrinol Metab· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting monogenic obesity: a systematic exome-wide workup of over 500 individuals.
Robert Künzel, Helene Faust, Linnaeus Bundalian, Matthias Blüher, Mariami Jasaszwili, Eric Wenzel

Int J Obes (Lond)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uniparental disomy leads to a novel cause of MC2R-related familial glucocorticoid deficiency type 1.
Amica Corda Müller-Nedebock, Eric Wenzel, Roland Pfäffle

Eur J Endocrinol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose escalation study to evaluate the safety and pharmacokinetic profile of tefibazumab in subjects with end-stage renal disease requiring hemodialysis.
Seth Hetherington, Michele Texter, Eric Wenzel, Joseph M Patti, Laurie Reynolds

Antimicrob Agents Chemother· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia.
J John Weems, James P Steinberg, Scott Filler, John W Baddley, G Ralph Corey, Eric Wenzel

Antimicrob Agents Chemother· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers.
Sandra Reilley, Eric Wenzel, Laurie Reynolds, Beth Bennett, Joseph M Patti

Antimicrob Agents Chemother· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis